Israel Englander Cumberland Pharmaceuticals Inc Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.01 $21,467 - $29,354	-14,604 Reduced 58.32%	10,436 $15,000
Q1 2023 May 15, 2023	BUY	$1.92 - $2.75 $8,954 - $12,826	4,664 Added 22.89%	25,040 $49,000
Q4 2022 Feb 14, 2023	BUY	$2.11 - $2.6 $42,993 - $52,977	20,376 New	20,376 $46,000

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $33.3M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.